An immigration raid this week on a Fresh Del Monte Produce
processing plant indicates that federal officials are continuing
their campaign to crack down on the industry's use of illegal
labour.
Critical Therapeutics is developing a new injectable formulation
for the treatment of asthma, and is the latest company to use
Captisol technology to achieve it.
JRS Pharma has entered into a collaboration with US firm CoreRX to
develop co-processed active pharmaceutical ingredients (APIs) using
JRS's high functionality excipient technology, Prosolv
Taiwan looks to benefit from a new alliance with Canada-based
ProMetic BioTherapeutics, which will provide a proprietary
manufacturing process to extract plasma proteins for drugs.
Schering-Plough and Kurve Technology have signed a new agreement
involving Kurve's nasal drug delivery device, which follows on the
heals of a partnership formed between the two companies last year.
Applikon Biotechnology has launched a new bioreactor controller,
the i-ControlXL, that has been designed to work with reactors of
any size, from any supplier.
A food industry coalition has launched a website designed to
provide information on the impact of the US policy on ethanol
of processors and consumers.
Major packaging player Rexam this morning announced that it will be
scooping up the plastics business of beleaguered firm
Owens-Illinois in a deal worth almost $2bn (€1.5bn).
Genzyme is expanding its manufacturing capabilities of
thymoglobulin in France as it moves to meet the growing demand and
future potential of the rabbit serum derivative.
A fund to promote biotech collaborations between Australia and New
Zealand has awarded a lump sum to two Antipodean firms which will
result in a new good manufacturing practice (GMP) compliant peptide
manufacturing plant in the under-served...
Danish firm Novozymes has launched its first range of animal-free
recombinant cell culture ingredients from its new business unit in
the UK, offering biopharmaceutical firms an alternative to
traditional serum-based production methods.
The fine chemicals division of Japanese contract manufacturer Daiso
has taken out a license to a highly-selective technology used to
synthesise chiral molecules.
Biopharma firm Vivalis has announced several licence agreements for
its proprietary cell line technology, adding to the list of
companies applying the technology to develop and commercialise new
human influenza vaccines.
MFIC is looking to introduce a new microfluidic system that
could help pharmaceutical and biotechnology companies to
manufacture difficult to formulate drugs.
Bosch Packaging Technology has launched the FLT1020 vial filling
system, a scaled-down version of full-sized filling units that is
geared specifically to use in the early stages of clinical trials.
A firm specialising in disposable equipment for the
biopharmaceutical industry has introduced a new revamped bioreactor
to its catalogue, dispensing with the traditional rocking and
rolling mechanisms used in many bioreactors.
The significance of the aborted deal between GlaxoSmithKline and
Cobra has been exaggerated due to GSK's high profile and is not the
end of the world, the British contract manufacturer said.
A UK-based technology company is part of a trio leading the way in
innovative supply chain solutions by combining real-time
temperature monitoring with a radio frequency identification (RFID)
tag for the pharmaceutical industry.
The critical role transgenic animals could play in the future of
biopharmaceutical production has been tackled by a task force in a
new report out this week.
Siemens is offering software support for the implementation of
Process Analytical Technology (PAT) in the pharmaceutical industry
with the launch of its Sipat package.
Thermo Fisher Scientific and Sartorius have signed a supply
agreement continuing the relationship between Sartorius and
Thermo's recently acquired TC Tech.
Bacterially derived nanocells that can deliver chemotherapeutic
drugs directly to cancer cells without the shortcomings of
liposomal or viral carriers could be in clinical trials by the end
of this year, an Australian biotechnology...
A transdermal patch for needle-free delivery of insulin and a
diagnostic test for rapid detection of meningococcal disease are
among the products under development by two new Australian
companies set up to commercialise the research...
Larger, high-value, reusable containers will drive demand for rigid
packaging by 3.5 per cent each year, reaching $6.6bn in 2011,
according to a new report.
German packaging company Klockner Pentaplast (KP) is investing more
than $20m (€15m) in a new pharmaceutical films manufacturing
facility in Aurangabad, India, in a bid to up its presence there.
As single-use technologies become more and more popular for use in
biopharmaceutical manufacturing, Pall is following market demands
bolstering its product line by adding a number of disposable
products to its portfolio.
Do-Coop Technologies, an Israeli company that uses nanotechnology
to create an equivalent of intracellular water as a medium for
enhancing existing chemical and biological reagents, reactions and
processes, has announced two "significant...
The ongoing intellectual property tussle between Pall and Entegris
continues with Pall claiming Entegris' Impact filter cartridge line
infringes four Pall patents.
Amylin Pharmaceuticals is expanding significantly on the US
manufacturing facility it is building in West Chester, Ohio for a
long-acting version of its injectable diabetes drug Byetta
(exenatide).
Prosonix and Bath University in the UK have won the Royal Society
of Chemistry's (RSC) Innovation award for the development of a tool
that enables the manufacture of crystalline pharmaceuticals of
specific sizes.
Italian glassware specialist Stevanato Group has consolidated the
engineering side of its business through the acquisition of fellow
Italian company Optrel.
Roche gave an update on its manufacturing of influenza drug Tamiflu
(oseltamivir) today, saying that while it had reached its target
capacity of 400 million doses a year, demand is running much lower.
Owens-Illinois, the US company best known as a manufacturer of
glass containers, has finalised a 50/50 joint venture with Pavisa
Industries to manufacture and sell plastic healthcare containers in
Mexico and other Latin markets.
ProBioGen, a specialist in mammalian cell engineering and cell
culture, has entered into two separate agreements to develop
therapeutic proteins with Egyptian drug manufacturer Minapharm..
A crop-based alternative to regular plastics that is biodegradeable
and compostable, developed by biotechnology firm Metabolix and
agriculture giant Archer Daniels Midland, is to be developed for
pharmaceutical applications.
Successful applications of cold-form film and security foil helped
the Pharma/Healthcare division of Austria's Constantia Packaging to
deliver above-average growth in 2006, the company reported.
Denmark's Novozymes has set up a dedicated business unit in the UK
to make and sell ingredients that support companies wanting to
produce biopharmaceuticals without using animal-derived
constituents.
A new method for generating large volumes of therapeutic antibodies
direct from Escherichia coli bacterium could knock weeks
off conventional mass-production processes that scale up to
mammalian cells, US researchers believe.
While technology cost and lack of a demonstrated return on
investment constitute the biggest barrier to adoption of radio
frequency identification (RFID) in the pharmaceutical industry, the
lack of a frequency standard runs these...
ATMI LifeSciences, a Belgian company that manufactures and supplies
film-based single-use packaging products for the biopharmaceutical
industry, has set up a joint venture, ATMI Austar LifeSciences,
Ltd, in the Shanghai area of China.
Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...
Bispecific antibodies (BisAbs), which can bind to two distinct antigens, are prone to high levels of aggregate (10-30%), challenging traditional platform...
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...
